Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2025-12-27 @ 11:18 PM
Study NCT ID:
NCT06643260
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-04-29
First Post:
2024-10-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy
Sponsor:
Can-Fite BioPharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-06
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-06
Completion Date Type:
ESTIMATED
First Submit Date:
2024-10-09
First Submit QC Date:
None
Study First Post Date:
2024-10-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-28
Last Update Post Date:
2025-04-29
Last Update Post Date Type:
ACTUAL